These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 17555340)
1. Relationship between vitamin D binding protein and aspirin resistance in coronary ischemic patients: a proteomic study. López-Farré AJ; Mateos-Cáceres PJ; Sacristán D; Azcona L; Bernardo E; de Prada TP; Alonso-Orgaz S; Fernández-Arquero M; Fernández-Ortiz A; Macaya C J Proteome Res; 2007 Jul; 6(7):2481-7. PubMed ID: 17555340 [TBL] [Abstract][Full Text] [Related]
2. Different expression of proteins in platelets from aspirin-resistant and aspirin-sensitive patients. Mateos-Cáceres PJ; Macaya C; Azcona L; Modrego J; Mahillo E; Bernardo E; Fernandez-Ortiz A; López-Farré AJ Thromb Haemost; 2010 Jan; 103(1):160-70. PubMed ID: 20062920 [TBL] [Abstract][Full Text] [Related]
3. [Acetylsalicylic acid (ASA) resistance in patients with ischemic heart disease (IHD) as bioindicator of the treatment strategy]. Malý J; Pecka M; Gregor J; Dulícek P; Blazek M; Malý R; Pudil R; Bláha M Cas Lek Cesk; 2005; 144 Suppl 3():23-9. PubMed ID: 16335259 [TBL] [Abstract][Full Text] [Related]
4. Variable platelet response to aspirin in patients with ischemic stroke. Hohlfeld T; Weber AA; Junghans U; Schumacher M; Boucher M; Schrör K; Siebler M Cerebrovasc Dis; 2007; 24(1):43-50. PubMed ID: 17519543 [TBL] [Abstract][Full Text] [Related]
5. Nitric oxide from mononuclear cells may be involved in platelet responsiveness to aspirin. López-Farré AJ; Modrego J; Azcona L; Guerra R; Segura A; Rodríguez P; Zamorano-León JJ; Lahera V; Macaya C Eur J Clin Invest; 2014 May; 44(5):463-9. PubMed ID: 24571196 [TBL] [Abstract][Full Text] [Related]
6. Partial inhibition of platelet thromboxane A2 synthesis by aspirin is associated with myonecrosis in patients with ST-segment elevation myocardial infarction. Valles J; Santos MT; Fuset MP; Moscardo A; Ruano M; Perez F; Piñon M; Breña S; Aznar J Am J Cardiol; 2007 Jan; 99(1):19-25. PubMed ID: 17196455 [TBL] [Abstract][Full Text] [Related]
7. Comparison of collagen versus adenosine diphosphate in detecting antiplatelet effect in patients with coronary artery disease. Li J; Jian Z; Huang L; Guo H; Huang J; Qian D; Fu W; Li A; Song Y Biomed Pharmacother; 2009 Sep; 63(8):608-12. PubMed ID: 19019624 [TBL] [Abstract][Full Text] [Related]
8. Relationship between endothelial dysfunction, oxidant stress and aspirin resistance in patients with stable coronary heart disease. Cheng G; Shan J; Xu G; Liu P; Zhou Y; Zhu Y; Lu X J Clin Pharm Ther; 2007 Jun; 32(3):287-92. PubMed ID: 17489881 [TBL] [Abstract][Full Text] [Related]
9. Screening for aspirin resistance in stable coronary artery patients by three different tests. Chakroun T; Addad F; Abderazek F; Ben-Farhat M; Hamdi S; Gamra H; Hassine M; Ben-Hamda K; Samama MM; Elalamy I Thromb Res; 2007; 121(3):413-8. PubMed ID: 17553552 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study. Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955 [TBL] [Abstract][Full Text] [Related]
12. A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease. Lordkipanidzé M; Pharand C; Schampaert E; Turgeon J; Palisaitis DA; Diodati JG Eur Heart J; 2007 Jul; 28(14):1702-8. PubMed ID: 17569678 [TBL] [Abstract][Full Text] [Related]
14. The effect of aspirin dosing on platelet function in diabetic and nondiabetic patients: an analysis from the aspirin-induced platelet effect (ASPECT) study. DiChiara J; Bliden KP; Tantry US; Hamed MS; Antonino MJ; Suarez TA; Bailon O; Singla A; Gurbel PA Diabetes; 2007 Dec; 56(12):3014-9. PubMed ID: 17848625 [TBL] [Abstract][Full Text] [Related]
15. Lack of association between aspirin responsiveness and seven candidate gene haplotypes in patients with symptomatic vascular disease. Kunicki TJ; Williams SA; Nugent DJ; Harrison P; Segal HC; Syed A; Rothwell PM Thromb Haemost; 2009 Jan; 101(1):123-33. PubMed ID: 19132198 [TBL] [Abstract][Full Text] [Related]
16. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial. Serebruany VL; Malinin AI; Pokov AN; Hanley DF Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263 [TBL] [Abstract][Full Text] [Related]
17. Aspirin response evaluated by the VerifyNow Aspirin System and light transmission aggregometry. Nielsen HL; Kristensen SD; Thygesen SS; Mortensen J; Pedersen SB; Grove EL; Hvas AM Thromb Res; 2008; 123(2):267-73. PubMed ID: 18499236 [TBL] [Abstract][Full Text] [Related]
18. Aspirin resistance: truth or dare. Lordkipanidzé M; Pharand C; Palisaitis DA; Diodati JG Pharmacol Ther; 2006 Dec; 112(3):733-43. PubMed ID: 16919334 [TBL] [Abstract][Full Text] [Related]
19. Incidence of aspirin resistance and its relationship with cardiovascular risk factors and graft function in renal transplant recipients. Acikel S; Yildirir A; Aydinalp A; Demirtas K; Bal U; Kaynar G; Ozin B; Karakayali H; Muderrisoglu H; Haberal M Transplant Proc; 2008 Dec; 40(10):3485-8. PubMed ID: 19100419 [TBL] [Abstract][Full Text] [Related]
20. Prevalence and risk factors for aspirin and clopidogrel resistance in patients with coronary artery disease or ischemic cerebrovascular disease. Kim H; Lee HK; Han K; Jeon HK Ann Clin Lab Sci; 2009; 39(3):289-94. PubMed ID: 19667414 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]